Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patients.
about
Prediction of Sustained Virological Response to Telaprevir-Based Triple Therapy Using Viral Response within 2 Weeks.Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching.Relative efficacy and safety of simeprevir and telaprevir in treatment-naïve hepatitis C-infected patients in a Japanese population: A Bayesian network meta-analysis.Efficacy and safety of telaprevir with pegylated interferon α-2a and ribavirin in Japanese patients.Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure.Efficacy of telaprevir-based therapy for difficult-to-treat patients with genotype 2 chronic hepatitis C in Japan.
P2860
Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Effectiveness and safety of re ...... chronic hepatitis C patients.
@en
Effectiveness and safety of re ...... chronic hepatitis C patients.
@nl
type
label
Effectiveness and safety of re ...... chronic hepatitis C patients.
@en
Effectiveness and safety of re ...... chronic hepatitis C patients.
@nl
prefLabel
Effectiveness and safety of re ...... chronic hepatitis C patients.
@en
Effectiveness and safety of re ...... chronic hepatitis C patients.
@nl
P2093
P2860
P356
P1433
P1476
Effectiveness and safety of re ...... chronic hepatitis C patients.
@en
P2093
Fumitaka Suzuki
Hiromitsu Kumada
Hitomi Sezaki
Kenji Ikeda
Masahiro Kobayashi
Norio Akuta
Satoshi Saitoh
Taito Fukushima
Tasuku Hara
Yasuji Arase
P2860
P304
P356
10.1111/HEPR.12268
P577
2014-01-08T00:00:00Z